Serum Beta-2 Microglobulin Level As a Useful Prognostic Marker Of Hodgkin Lymphoma
Yuki Nakajima(Fujisawa City Hospital), Yoshiaki Ishigatsubo(Yokohama City University), Masatsugu Tanaka(Kanagawa Prefectural Hospital Organization), Megumi Itabashi(Shizuoka Red Cross Hospital), Hirotaka Takasaki(Kanagawa Prefectural Hospital Organization), Naoto Tomita(St. Marianna University School of Medicine), Daisuke Ishibashi(Fukuoka University), Hiroyuki Takahashi(Yokohama City University), Yasufumi Ishiyama(Kanagawa Prefectural Hospital Organization), Rika Kawasaki(Yokohama City University Medical Center), Eri Yamamoto(Yokohama City University), Katsumichi Fujimaki(Fujisawa City Hospital), Ayumi Numata(Yokohama City University Medical Center), Satoshi Koyama(Shizuoka Red Cross Hospital), Rika Sakai(Yokohama City University Medical Center), Shigeki Motomura(Kanagawa Prefectural Hospital Organization), Hideyuki Kuwabara(Yokohama City University Medical Center), Reina Watanabe(Kanagawa Prefectural Hospital Organization), Chizuko Hashimoto(Yamato Municipal Hospital)
Cited by 4
Related Papers
Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study
|Clinical Infectious Diseases|2015|149
Comparison of Outcomes of 8/8 and 7/8 Allele–Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia
|Biology of Blood and Marrow Transplantation|2015|119
Nucleosides and nucleotides. 100. 2'-C-Cyano-2'-deoxy-1-.beta.-D-arabinofuranosylcytosine (CNDAC): design of a potential mechanism-based DNA-strand-breaking antineoplastic nucleoside
|Journal of Medicinal Chemistry|1991|85
Identification of human DAN gene, mapping to the putative neuroblastoma tumor suppressor locus.
|PubMed|1994|81
Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large <scp>B</scp>‐cell lymphoma in the rituximab era
|European Journal Of Haematology|2013|58